Compare Citius Pharmaceuticals Inc (CTXR) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs HCA Health Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while HCA Health Inc trades at $411 (market cap $89.08B). The key difference: HCA Health Inc is far larger — about 4451.8× Citius Pharmaceuticals Inc's market cap, and HCA Health Inc pays a 0.76% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | HCA | |
|---|---|---|
Market Cap | $20.01M | $89.08B |
Sector | Health | Health |
52-Week High | $1.82 | $545.13 |
52-Week Low | $0.48 | $361.32 |
Enterprise Value | $16.23M | $139.62B |
Dividend Yield | — | 0.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
